Not yet recruitingNCT07525492Updated Apr 13, 2026

Die-logue Program for Community Dwelling Adults: A Randomized Controlled Trial

An interventional study of Death Conversation and Online ACP Education in Death Attitude (Implicit/Explicit), Death Anxiety and End of Life Care, sponsored by National University of Singapore. Not yet recruiting at 1 site in Singapore. Open to participants aged 40 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by National University of Singapore · Not applicable, Interventional, and Prevention

Phase: Not applicable
Study type: Interventional
Enrollment: 148
Allocation: Randomized
Ages: 40 Years to 60 Years
Sex: All

Study summary

The goal of this clinical trial is to evaluate whether the Die-logue program can improve attitudes toward death, coping with death, and readiness for advance care planning (ACP) among community-dwelling middle-aged adults aged 40-60 years who have not completed any advance directives and not diagnosed with any life limiting diseases.

This study aims to address the following research questions:

Does the Die-logue program improve community-dwelling middle-aged adults' attitudes towards death, ability to cope with death, readiness and uptake for Advanced Care Planning (ACP).
What are community-dwelling middle-aged adults' perceptions of advance care planning, death and dying, and their experiences of participation in the Die-logue program.

Researchers will compare participants who receive the Die-logue program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve attitudes toward death, coping with death, and readiness for ACP.

Participants will:

Complete online questionnaires measuring attitudes toward death, coping with death, and readiness for advance care planning.
Participate in a facilitator-led group discussion session about perceptions of death, coping with death, and readiness for ACP (intervention group only).
Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
Complete follow-up surveys, including a 6-month follow-up assessing whether they have undertaken advance care planning.

Conditions studied

Death Attitude (Implicit/Explicit)
Death Anxiety
End of Life Care
Advanced Care Planning (ACP)

Browse trials for

Necrophobia 26

Keywords

Death Conversation
Death Anxiety
Advance Care Planning
Death Attitude

In context

Necrophobia

26 studies on the registry are indexed under Necrophobia; 11 are open to participants now.

This study's planned enrollment of 148 is above the median of 70 across 22 interventional studies indexed under Necrophobia.

Browse Necrophobia studies →

Lead sponsor

National University of Singapore is the lead sponsor of 212 studies on the registry; 54 are open to participants now.

Browse National University of Singapore studies →

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 40 Years to 60 Years
Sexes eligible: All
Accepts healthy volunteers: Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Between the ages of 40 to 60 years
Able to comprehend the English language
Have not completed any form of advance directives
Able and willing to participate in the Die-logue programme and surveys

Exclusion criteria

Exclusion Criteria:

Individuals diagnosed with any life limiting diseases
Individuals with self-reported history of mental health disorders or neurological disorders

Study design

Phase: Not applicable
Primary purpose: Prevention
Allocation: Randomized
Intervention model: Parallel assignment
Masking: None (open label)
Enrollment: 148 participants (estimated)

Study arms

Experimental
Intervention Group
Participants in this arm will receive the two-session Die-logue Program. Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering: 1. Perceptions of death and dying. 2. Coping with death. 3. Readiness for Advance Care Planning (ACP). Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums.
Behavioral: Death Conversation · Behavioral: Online ACP Education
Active comparator
Control Group
Participants in this arm will only receive the online ACP education component, identical to Session 2 of the Die-logue programme. No facilitator-led group discussions are provided.
Behavioral: Online ACP Education

Interventions

BehavioralDeath Conversation
On site, facilitator-led group discussion lasting 2 hours, covering: 1) Perceptions of death and dying. 2) Coping with death. 3) Readiness for Advance Care Planning (ACP)
BehavioralOnline ACP Education
An online asynchronous learning session with short videos on ACP with discussion forums.

What researchers measure

Primary outcomes

Death Attitudes
Death Attitude Profile Revised Scale (DAP-R)
Time frame: Before intervention
Death Attitudes
Death Attitude Profile Revised Scale (DAP-R)
Time frame: Immediately after intervention

Secondary outcomes

Coping with Death
Coping with Death Scale - Short Form (CDS-SF)
Time frame: Before intervention
Coping with Death
Coping with Death Scale - Short Form (CDS-SF)
Time frame: Immediately after intervention
Coping with Death
Coping with Death Scale - Short Form (CDS-SF)
Time frame: 6 months after intervention
Death Attitudes
Death Attitude Profile Revised Scale (DAP-R)
Time frame: 6 months after intervention
Readiness for Advance Care Planning
Readiness for Advance Care Planning (RACP) Scale
Time frame: Before intervention
Readiness for Advance Care Planning
Readiness for Advance Care Planning (RACP) Scale
Time frame: Immediately after intervention
Readiness for Advance Care Planning
Readiness for Advance Care Planning (RACP) Scale
Time frame: 6 months after intervention
Uptake of Advance Care Planning
Self-reported completion of Advance Care Planning Activities
Time frame: 6 months after intervention

Study locations

1 site

National University of Singapore
Singapore, Singapore
21 other open studies at this site →
- Darryl Ang, PhD · Contact · darrylang@nus.edu.sg · +65 65167792

Timeline

Tracking since Sep 25, 2026

ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2026; primary completion for Dec 2027, 20 months later.

Of 16 interventional studies with no phase under Necrophobia, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 13. This study's planned 20 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered: Apr 6, 2026
First posted: Apr 13, 2026
StartEst.: Apr 1, 2026
Primary completionEst.: Dec 31, 2027
CompletionEst.: Dec 31, 2027
Last update: Apr 13, 2026

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT07525492
Lead sponsor: National University of Singapore
Responsible party: Ang Wei How Darryl (Research Assistant Professor, National University of Singapore) — Principal investigator
First posted: Apr 13, 2026
Start date: Apr 1, 2026 (estimated)
Primary completion: Dec 31, 2027 (estimated)
Completion: Dec 31, 2027 (estimated)
Last update: Apr 13, 2026

Study contacts

Darryl Ang, PhD

Contact

darrylang@nus.edu.sg

+65 65167792

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Necrophobia →

Other studies from this sponsor

National University of Singapore →

Start the discussion